Home page > Publications > Papers of Interest > Metronomic in children
Metronomic in children
Metronomic Chemotherapy for Burkitt Lymphoma in a Patient With HIV
Pankaj Dwivedi, Atul Kapse, Chaitali Bangurwar, Ankita Tamhane, Shripad Banavali from the Departments of Pediatric Oncology, Nuclear Medicine, Pathology, National Cancer Institute, Nagpur and Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India have published in the Journal of Pediatric Hematology Oncology a cas report entiteld : (...)
Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study
In the last issue of the J Pediatr Hematol Oncol, Yukari Sakurai, Fuminori Iwasaki, Ayana Hirose, Naoya Matsumoto, Naoyuki Miyagawa, Dai Keino, Tomoko Yokosuka, Satoshi Hamanoue, Masakatsu Yanagimachi, Masae Shiomi, Shoko Goto, Mio Tanaka , Yukichi Tanaka, Kumiko Nozawa, Hiroaki Goto from the divisions of Division of Hematology/Oncology, of Pathology (...)
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
As part of a special issue entitled: [Clinical Applications of Metronomic Chemotherapy in the Journal of Clinical Medicine , Banchi M, Fini E, Crucitta S, Bocci G from the Department of Clinical and Experimental Medicine, University of Pisa, VItaly have just published a review article : Metronomic Chemotherapy in Pediatric Oncology: From Preclinical (...)
Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package
A Bahl A and S Bakhshi from the Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences in New Delhi have just published a reveiw about metronomic chemotherapy in the Indian Journal of Pediatrics you can acces the full text at the following adress : http://www.springerlink.com/content...
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
Pramanik R, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D, Bakhshi S from the Department of Medical Oncology, Department of Pediatric Surgery, Department of Pharmacology, Department of Radiodiagnosis, Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India have just published in JAMA Oncology a (...)
Metronomic Maintenance Therapy in Refractory Acute Myeloblastic Leukemia with Monosomy 7
Mahdi Shahriari, Babak Abdolkarimi, Fazl Saleh and Pooria Salajeghe from the Department of Pediatrics, Hematology-Oncology Branch, Amir Oncology Hospital, Shiraz University of Medical Sciences, Shiraz, Iran have just published a case report entitled : Metronomic Maintenance Therapy in Refractory Acute Myeloblastic Leukemia with Monosomy 7 in the (...)
Metronomic therapy for malignant peripheral nerve sheath tumor in NF1.
Chaudhary N and Borker A. from the Pediatric Hematology Oncology Unit, Department of Pediatrics, Kasturba Medical College, Manipal University, Manipal, Karnataka have just reported in Pediatric Blood and Cancer about the successfull use of metronomic chemotherapy for the treatment of a malignant peripheral nerve sheath tumor in a patient with NF1. (...)
Metronomic therapy in pediatric oncology: A snapshot.
The Pediatric Blood and Cancer journal has just published a review about the use of metronomic chemotherapy in children entitled : Metronomic therapy in pediatric oncology: A snapshot. The article has been written by Pramanik R, Bakhshi S from the department of Medical Oncology, Dr. B. R.A. Institute Rotary Cancer Hospital, All India Institute of (...)
Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in Drug-Resistant Neuroblastoma Preclinical Models.
Zhang L, Wu B, and Baruchel S from the New Agent and Innovative Therapy Program, and Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada have just published in Translational Oncology a preclinical paper entitled : Oral Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in ALKF1174L Drug-Resistant (...)
Metronomics is as effective as current standard for recurrent high risk neuroblastoma
Frank Berthold, Marc Hömberg, Inna Proleskovskaya, Pavel Mazanek, Margarita Belogurova, Angela Ernst & Jaroslav Sterba from the Department of Pediatric Oncology and Hematology, University of Cologne, Germany; Department of Pediatric Oncology and Hematology, University of Minsk, Belarus; Department of Pediatric Oncology and Hematology, University of (...)
